About Sequelae
Sequelae is a private company based in Minneapolis, Minnesota, incorporated in 2023 in Delaware. It has reported $80,222,750 raised in three offerings on Form D since April 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 7, 2025 | Nov 18, 2025 | $222,750of $1.4M target | 2 | $111K | EquityRule 506(b) | Form D ↗ |
| Apr 25, 2024 | May 8, 2024 | $20,000,000fully sold | 2 | $10.0M | EquityRule 506(b) | Form D ↗ |
| Apr 18, 2023 | Apr 12, 2024 | $60,000,000fully sold | 7 | $8.5M | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, three offerings | $80,222,750 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Sequelae's Form D filed Nov 18, 2025.
AZ
Albert Zimmerli
Director
RF
Rushika Fernandopulle
Director
ST
Sara Taylor
Executive officer
MC
Mike Christy
Executive officer
GJ
AS
Amy Schulman
Director
KE
Ken Ehlert
Executive officer and director
DW
David Wichmann
Director
MB
Mark Briesacher
Executive officer
Earlier filings also listed Shiraz Fagan (executive officer, last listed May 2024), Mark Pollman (executive officer, last listed May 2024), David Wichman (director, last listed May 2024) and Mark Pollmann (executive officer, last listed Apr 2024).